4.7 Review

Tubulin degradation: Principles, agents, and applications

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Chemistry, Medicinal

New drug approvals for 2021: Synthesis and clinical applications

Shuo Yuan et al.

Summary: Fifty new drugs, including 36 chemical entities and 14 biologics, were approved by the FDA in 2021. Among these, 31 new small molecule drugs showed promising leads for the development of similar drugs with improved therapeutic efficacy. This review focuses on the clinical applications and synthetic methods of the 29 small molecule drugs approved by the FDA in 2021, aiming to provide insights for the development of more efficient and practical synthetic technologies in new drug discovery.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Chemistry, Medicinal

Novel Small-Molecule PD-L1 Inhibitor Induces PD-L1 Internalization and Optimizes the Immune Microenvironment

Chengliang Sun et al.

Summary: S4-1 is an innovative small-molecule inhibitor of PD-L1 that effectively alters the PD-L1/PD-1 interaction, enhances cytotoxicity of immune cells towards tumor cells, and shows significant tumor growth inhibition in vivo. It also activates T-cells and reverses the inhibitory tumor microenvironment.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Chemistry, Medicinal

Discovery of novel tranylcypromine-based derivatives as LSD1 inhibitors for gastric cancer treatment

Qi-Sheng Ma et al.

Summary: Histone lysine specific demethylase 1 (LSD1), an important epigenetic regulator, is a promising target for anticancer drug discovery. This study designed and synthesized a series of tranylcypromine-based derivatives, among which compound 12u exhibited the most potent inhibitory potency on LSD1 and showed effective antiproliferative effects on MGC-803, KYSE450, and HCT-116 cells. Further investigations demonstrated that compound 12u directly targeted LSD1, leading to increased levels of mono-/bi-methylation of H3K4 and H3K9. Additionally, compound 12u induced apoptosis, differentiation, and inhibition of migration and cell stemness in MGC-803 cells, suggesting its potential as an active LSD1 inhibitor for gastric cancer.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Chemistry, Medicinal

Discovery of novel N-benzylarylamide-dithiocarbamate based derivatives as dual inhibitors of tubulin polymerization and LSD1 that inhibit gastric cancers

Xin-Ying Yuan et al.

Summary: In this study, N-benzylarylamide-dithiocarbamate based derivatives were synthesized and tested for their anticancer activities. Compound I-25 (also known as MY-943) showed potent inhibitory effects against multiple cancer cells, and induced cell cycle arrest, apoptosis, and inhibition of cell migration. The compound effectively inhibited tubulin polymerization and suppressed LSD1 activity. Molecular docking studies revealed the binding modes of compound I-25 with tubulin and LSD1. In vivo experiments demonstrated that compound I-25 effectively reduced the weight and volume of gastric cancer without noticeable toxicity. This study highlights the potential of N-benzylarylamide-dithiocarbamate derivatives as dual inhibitors targeting tubulin polymerization and LSD1 in gastric cancers.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Biochemistry & Molecular Biology

The dual FAK-HDAC inhibitor MY-1259 displays potent activities in gastric cancers in vitro and in vivo

Jian Song et al.

Summary: This study reports the discovery of a new compound MY-1259 as a dual FAK and HDAC6 inhibitor, which shows promising treatment effects on gastric cancers in vitro and in vivo.

BIOORGANIC CHEMISTRY (2023)

Article Chemistry, Medicinal

Design, synthesis and evaluation of novel bis-substituted aromatic amide dithiocarbamate derivatives as colchicine site tubulin polymerization inhibitors with potent anticancer activities

Ya-Xin Sun et al.

Summary: This study designed a series of novel bis-substituted aromatic amide dithiocarbamate derivatives as tubulin inhibitors with potential anticancer activities. Among them, compound 20q exhibited the most potent antiproliferative activity and was identified as a tubulin inhibitor targeting the colchicine binding site.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Chemistry, Medicinal

Structure-Based Design and Synthesis of N-Substituted 3-Amino-β-Carboline Derivatives as Potent αβ-Tubulin Degradation Agents

Yong Li et al.

Summary: Compound 12b has been found to promote alpha beta-tubulin degradation and display potent antiproliferative activity against various tumor cells. It binds to the colchicine site and promotes tubulin degradation through the ubiquitin-proteasome pathway. In cell experiments and mouse models, 12b has shown significant tumor-suppressive effects.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Medicine, General & Internal

Cancer statistics in China and United States, 2022: profiles, trends, and determinants

Changfa Xia et al.

Summary: The study compared the latest cancer profiles, trends, and determinants between China and the USA in 2022. China has a higher incidence of lung cancer, while the USA has more cases of breast cancer. Recent years have seen a significant decrease in lung and colorectal cancer rates in the USA, while liver cancer rates have slightly increased. In China, rates for stomach, liver, and esophageal cancer have decreased gradually, but colorectal cancer rates have increased for the whole population.

CHINESE MEDICAL JOURNAL (2022)

Review Biochemistry & Molecular Biology

Targeted protein degradation: Emerging concepts and protein state-specific targeting principles

Andrew J. Tao et al.

Summary: Targeted protein degraders are small molecules that can rapidly reduce the expression of target proteins. Recent studies have shown that degraders with specificity can be developed for subpopulations of target proteins.

CURRENT OPINION IN CHEMICAL BIOLOGY (2022)

Article Environmental Sciences

Cytotoxic screening and antibacterial activity of Withaferin A

Altevir Rossato Viana et al.

Summary: This study evaluated the biological activity of Withaferin A and found that it exhibited cytotoxic activity against tumor cells, increased ROS production in tumor cells, and showed bactericidal and antibiofilm activity against bacteria.

JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES (2022)

Article Biochemistry & Molecular Biology

True-atomic-resolution insights into the structure and functional role of linear chains and low-barrier hydrogen bonds in proteins

Valentin Borshchevskiy et al.

Summary: High-resolution structures of bacteriorhodopsin reveal the important roles of hydrogen bond chains and low-barrier hydrogen bonds in proton transport and storage, as well as long-range communication and signaling in proteins.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2022)

Article Chemistry, Medicinal

Discovery of novel coumarin-indole derivatives as tubulin polymerization inhibitors with potent anti-gastric cancer activities

Jian Song et al.

Summary: This study designed, synthesized, and evaluated novel coumarin-indole derivatives as tubulin polymerization inhibitors targeting the colchicine binding site. Compound MY-413 showed potent inhibitory activities against gastric cancer cells, inhibited tubulin polymerization, and MAPK signaling pathway, induced cell apoptosis and proliferation inhibition both in vitro and in vivo. In addition, MY-413 significantly inhibited tumor growth in xenograft tumor models without obvious toxicity. Overall, MY-413 is a promising lead compound for further investigation as a potential anti-gastric cancer agent.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)

Review Biochemistry & Molecular Biology

Anticancer and Anti-Metastatic Role of Thymoquinone: Regulation of Oncogenic Signaling Cascades by Thymoquinone

Ammad Ahmad Farooqi et al.

Summary: Cancer is a life-threatening disease that has been extensively studied in the past three decades. Thymoquinone, a natural product, has shown promising potential in cancer chemoprevention through its multifunctionality. Further research is needed to transition thymoquinone from preclinical studies to clinical trials.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Chemistry, Medicinal

Small Molecules Promote Selective Denaturation and Degradation of Tubulin Heterodimers through a Low-Barrier Hydrogen Bond

Jianhong Yang et al.

Summary: We report a novel mechanism of selectively degrading target proteins mediated by low-barrier hydrogen bonds, and identified a compound capable of promoting degradation through this mechanism.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Biochemistry & Molecular Biology

Therapeutic implications and clinical manifestations of thymoquinone

Manzar Alam et al.

Summary: Thymoquinone (TQ), a natural phytochemical found in Nigella sativa, has been proven to have anti-cancer, anti-oxidant, and anti-inflammatory properties, and exhibits antitumor activity by modulating multiple pathways and molecular targets.

PHYTOCHEMISTRY (2022)

Article Chemistry, Medicinal

Discovery of N-benzylarylamide derivatives as novel tubulin polymerization inhibitors capable of activating the Hippo pathway

Jian Song et al.

Summary: The novel compound showed potent antiproliferative activities by targeting the colchicine binding site of tubulin and activating the Hippo pathway, making it a promising agent for cancer therapy.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Biochemistry & Molecular Biology

Subtilisin from Bacillus amyloliquefaciens induces apoptosis in breast cancer cells through ubiquitin-proteasome-mediated tubulin degradation

Nanda Singh et al.

Summary: By studying the anti-cancer properties of subtilisin, it was found that subtilisin can induce apoptosis in breast and colon cancer cells by degrading tubulin, without affecting normal cells. This study provides new insights for the development of novel anti-cancer therapies.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2022)

Review Pharmacology & Pharmacy

Evaluating anticancer properties of Withaferin A-a potent phytochemical

Maushma Atteeq

Summary: Withaferin A, derived from the plant Withania somnifera, has gained great attention for its anticancer properties. It interacts with key proteins involved in cancer cell activity, leading to apoptosis. Additionally, Withaferin A generates reactive oxidative species, activates Par-4, induces endoplasmic reticulum stress, and activates p53, contributing to its pro-apoptotic effects.

FRONTIERS IN PHARMACOLOGY (2022)

Article Chemistry, Multidisciplinary

An NMIDLINE HORIZONTAL ELLIPSISHMIDLINE HORIZONTAL ELLIPSISN low-barrier hydrogen bond preorganizes the catalytic site of aspartate aminotransferase to facilitate the second half-reaction

Victoria N. Drago et al.

Summary: The study focuses on the role of pyridoxal 5'-phosphate (PLP)-dependent enzyme in promoting various chemical reactions and the use of neutron crystallography to visualize the electron states of PLP and enzyme active sites. The researchers report a joint X-ray/neutron structure of aspartate aminotransferase (AAT) with pyridoxamine 5'-phosphate (PMP), providing evidence of a low-barrier hydrogen bond (LBHB) interaction. The findings suggest that the LBHB facilitates the preorganization of the active site for the subsequent reaction.

CHEMICAL SCIENCE (2022)

Review Biochemistry & Molecular Biology

Targeted protein degradation: mechanisms, strategies and application

Lin Zhao et al.

Summary: Traditional drug discovery focuses on direct regulation of protein activity. However, the emerging targeted protein degradation (TPD) technologies, such as PROTAC, provide potential approaches to remove disease-associated proteins by utilizing cells' degradation machinery. These TPD strategies, including molecular glue, LYTAC, and AbTAC, expand the scope of TPD and offer fresh insights into drug discovery.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)

Article Biochemistry & Molecular Biology

Low barrier hydrogen bonds in protein structure and function

M. Trent Kemp et al.

Summary: LBHBs are a special type of short hydrogen bond characterized by equal sharing of a hydrogen atom. The debate over their existence and catalytic role in proteins has been intense, but experiments show they are significantly stronger than standard HBs in terms of enthalpy.

BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2021)

Article Biochemistry & Molecular Biology

Thymoquinone attenuates doxorubicin-cardiotoxicity in rats

Derya Karabulut et al.

Summary: Thymoquinone shows significant cardioprotective effects against doxorubicin-induced cardiotoxicity in rats, reducing apoptosis and oxidative stress. This suggests that thymoquinone could be an important agent in protecting the heart from doxorubicin toxicity.

JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2021)

Article Chemistry, Medicinal

Progress of tubulin polymerization activity detection methods

Ting Zhu et al.

Summary: Tubulin, an important target in tumor therapy, has been a hot spot in the field of antineoplastic drugs in recent years. Researchers have faced challenges in screening out polymerization inhibitors with simple operation, high efficiency, and low cost due to the diversity of compound structure types.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2021)

Editorial Material Biochemistry & Molecular Biology

The Rise of Molecular Glues

Stuart L. Schreiber

Summary: The 30th anniversary of the discovery of cyclosporin A and FK506 marks a milestone in understanding their role as molecular glues that induce new protein-protein interactions. The emergence of new molecular-glue probes and medications has sparked interest in this field.
Article Biochemistry & Molecular Biology

Microtubule associated proteins as targets for anticancer drug development

Sadiya Khwaja et al.

Summary: The dynamic equilibrium of tubulin-microtubule is crucial for cell survival, making it an important target for cancer drug development. Microtubules play essential roles in mitosis and cell multiplication, while MAPs interact with microtubules to affect their stability. Post-translational modifications of lysine-40 and HDAC inhibitors have significant roles in gene expression and anticancer properties, respectively.

BIOORGANIC CHEMISTRY (2021)

Review Biochemistry & Molecular Biology

Natural Products Targeting the Mitochondria in Cancers

Yue Yang et al.

Summary: Natural compounds are abundant sources of anticancer drugs, with significant antitumor effects through regulating mitochondria. Research on how natural products regulate mitochondria in recent years is valuable for the development of new anticancer drugs.

MOLECULES (2021)

Article Oncology

Optimized EGFR Blockade Strategies in EGFR Addicted Gastroesophageal Adenocarcinomas

Simona Corso et al.

Summary: The study highlights EGFR amplification as a driving factor of aggressive behavior and poor prognosis in gastric cancer, with EGFR inhibitors showing activity in patients with EGFR copy number gain. Additionally, the combination of EGFR and mTOR inhibitors shows promise in overcoming primary resistance mechanisms.

CLINICAL CANCER RESEARCH (2021)

Review Chemistry, Medicinal

New drug approvals for 2020: Synthesis and clinical applications

Shuo Yuan et al.

Summary: In 2020, the U.S. FDA approved 53 new drugs, consisting of 38 chemical entities and 15 biologics. Among these, 34 new small molecule drugs and 4 new diagnostic agents show promising leads for further drug development.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Review Nanoscience & Nanotechnology

Nanomedicines for combating multidrug resistance of cancer

Ya-Xuan Zhu et al.

Summary: Chemotherapy is often used to inhibit the proliferation of cancer cells, but the emergence of multidrug-resistant cancer cells has become a significant threat. The causes of multidrug resistance can be classified into drug efflux pump activation and non-efflux pump-related mechanisms. Efforts to overcome multidrug resistance include developing synergistic therapeutic strategies combining chemotherapy with other modalities.

WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2021)

Article Multidisciplinary Sciences

Cevipabulin-tubulin complex reveals a novel agent binding site on α-tubulin with tubulin degradation effect

Jianhong Yang et al.

Summary: Our study reveals that the microtubule-targeting drug cevipabulin, in addition to binding to the vinblastine site, may also bind to a new site on alpha-tubulin, leading to destabilization and degradation of microtubules. This finding confirms the existence of a new agent binding site on alpha-tubulin and provides insights for the development of tubulin degraders as a new generation of antimicrotubule drugs targeting this novel site.

SCIENCE ADVANCES (2021)

News Item Biochemistry & Molecular Biology

Molecular glue concept solidifies

Kheewoong Baek et al.

NATURE CHEMICAL BIOLOGY (2020)

Review Chemistry, Multidisciplinary

Prey for the Proteasome: Targeted Protein Degradation-A Medicinal Chemist's Perspective

Laura M. Luh et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)

Review Biochemistry & Molecular Biology

Mechanisms of Multidrug Resistance in Cancer Chemotherapy

Karol Bukowski et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Cell Biology

Tubulin Resists Degradation by Cereblon-Recruiting PROTACs

Ivana Gasic et al.

Editorial Material Biochemistry & Molecular Biology

Prospecting for molecular glues

Willem den Besten et al.

NATURE CHEMICAL BIOLOGY (2020)

Review Cell Biology

The dialogue between the ubiquitin-proteasome system and autophagy: Implications in ageing

Jia Liang Sun-Wang et al.

AGEING RESEARCH REVIEWS (2020)

Article Biochemistry & Molecular Biology

Covalent modification of Cys-239 in -tubulin by small molecules as a strategy to promote tubulin heterodimer degradation

Jianhong Yang et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2019)

Review Biochemistry & Molecular Biology

Advances in targeted degradation of endogenous proteins

Sascha Roth et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2019)

Review Chemistry, Medicinal

Targeting Tubulin-colchicine Site for Cancer Therapy: Inhibitors, Antibody-Drug Conjugates and Degradation Agents

Yongtao Duan et al.

CURRENT TOPICS IN MEDICINAL CHEMISTRY (2019)

Article Agriculture, Multidisciplinary

Benzyl Isothiocyanate and Phenethyl Isothiocyanate Inhibit Adipogenesis and Hepatosteatosis in Mice with Obesity Induced by a High-Fat Diet

Wei-Ting Chuang et al.

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2019)

Article Pharmacology & Pharmacy

Withaferin A Improves Nonalcoholic Steatohepatitis in Mice

Daxesh P. Patel et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)

Article Pharmacology & Pharmacy

The Natural Compound Withaferin A Covalently Binds to Cys239 of β-Tubulin to Promote Tubulin Degradation

Jianhong Yang et al.

MOLECULAR PHARMACOLOGY (2019)

Article Chemistry, Medicinal

Molecular diversity of trimethoxyphenyl-1,2,3-triazole hybrids as novel colchicine site tubulin polymerization inhibitors

Dong-Jun Fu et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)

Review Biochemistry & Molecular Biology

Targeted protein degradation and the enzymology of degraders

Stewart L. Fisher et al.

CURRENT OPINION IN CHEMICAL BIOLOGY (2018)

Editorial Material Pharmacology & Pharmacy

The Neuroprotective Effects of Thymoquinone: A Review

Tahereh Farkhondeh et al.

DOSE-RESPONSE (2018)

Review Chemistry, Medicinal

Recent advances in trimethoxyphenyl (TMP) based tubulin inhibitors targeting the colchicine binding site

Ling Li et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)

Article Chemistry, Medicinal

The polypharmacology of natural products

Tu T. Ho et al.

FUTURE MEDICINAL CHEMISTRY (2018)

Review Urology & Nephrology

An Overview on Renoprotective Effects of Thymoquinone

Hanieh Shaterzadeh-Yazdi et al.

KIDNEY DISEASES (2018)

Article Biochemistry & Molecular Biology

Short Carboxylic Acid-Carboxylate Hydrogen Bonds Can Have Fully Localized Protons

Jiusheng Lin et al.

BIOCHEMISTRY (2017)

Review Biochemistry & Molecular Biology

Proteasome Structure and Assembly

Lauren Budenholzer et al.

JOURNAL OF MOLECULAR BIOLOGY (2017)

Article Chemistry, Physical

Structure of Dynamic, Taxol-Stabilized, and GMPPCP-Stabilized Microtubule

Avi Ginsburg et al.

JOURNAL OF PHYSICAL CHEMISTRY B (2017)

Review Pharmacology & Pharmacy

Targeted protein degradation by PROTACs

Taavi K. Neklesa et al.

PHARMACOLOGY & THERAPEUTICS (2017)

Review Biochemistry & Molecular Biology

The Logic of the 26S Proteasome

Galen Andrew Collins et al.

Review Chemistry, Multidisciplinary

Small-Molecule PROTACS: New Approaches to Protein Degradation

Momar Toure et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)

Review Cell Biology

Microtubule and microtubule associated protein anomalies in psychiatric disease

Francesca Marchisella et al.

CYTOSKELETON (2016)

Editorial Material Biochemistry & Molecular Biology

Obesity: will withaferin win the war?

Paul T. Pfluger et al.

NATURE MEDICINE (2016)

Article Multidisciplinary Sciences

Pironetin reacts covalently with cysteine-316 of α-tubulin to destabilize microtubule

Jianhong Yang et al.

NATURE COMMUNICATIONS (2016)

Article Chemistry, Multidisciplinary

Structural Basis of Microtubule Stabilization by Laulimalide and Peloruside A

Andrea E. Prota et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)

Article Multidisciplinary Sciences

A new tubulin-binding site and pharmacophore for microtubule-destabilizing anticancer drugs

Andrea E. Prota et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)

Article Food Science & Technology

Crucial facts about health benefits of popular cruciferous vegetables

Shivapriya Manchali et al.

JOURNAL OF FUNCTIONAL FOODS (2012)

Article Oncology

Combinatorial effects of thymoquinone on the anti-cancer activity of doxorubicin

Katharina Effenberger-Neidnicht et al.

CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)

Article Pharmacology & Pharmacy

Characterization of the Covalent Binding of N-Phenyl-N′-(2-chloroethyl)ureas to β-Tubulin: Importance of Glu198 in Microtubule Stability

Sebastien Fortin et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)

Review Biotechnology & Applied Microbiology

Microtubule-binding agents: a dynamic field of cancer therapeutics

Charles Dumontet et al.

NATURE REVIEWS DRUG DISCOVERY (2010)

Review Plant Sciences

Microtubule-Binding Natural Products for Cancer Therapy

Qing-Xi Yue et al.

PLANTA MEDICA (2010)

Article Biochemistry & Molecular Biology

The microtubule-targeting agent T0070907 induces proteasomal degradation of tubulin

Gianni Harris et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)

Article Biochemistry & Molecular Biology

Cancer Preventive Isothiocyanates Induce Selective Degradation of Cellular α- and β-Tubulins by Proteasomes

Lixin Mi et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2009)

Review Biochemistry & Molecular Biology

Microtubule assembly dynamics: An attractive target for anticancer drugs

Parminder Singh et al.

IUBMB LIFE (2008)

Article Biochemistry & Molecular Biology

Structure of the Human 26S Proteasome

Paula C. A. da Fonseca et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2008)

Article Biochemistry & Molecular Biology

Covalent binding to tubulin by isothiocyanates - A mechanism of cell growth arrest and apoptosis

Lixin Mi et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2008)

Review Medicine, Research & Experimental

PPAR gamma Inhibitors as Novel Tubulin-Targeting Agents

Katherine L. Schaefer

PPAR RESEARCH (2008)

Article Biochemistry & Molecular Biology

E3-independent monoubiquitination of ubiquitin-binding proteins

Daniela Hoeller et al.

MOLECULAR CELL (2007)

Article Biochemistry & Molecular Biology

Mutations affecting β-tubulin folding and degradation

YQ Wang et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2006)

Article Multidisciplinary Sciences

Structural basis for the regulation of tubulin by vinblastine

B Gigant et al.

NATURE (2005)

Review Oncology

Microtubules as a target for anticancer drugs

MA Jordan et al.

NATURE REVIEWS CANCER (2004)